References
- Almog R., Low M., Cohen D., Robin G., Ashkenazi S., Bercovier H., et al. Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990–1991. Infection 1999; 27: 212–217
- Bar-Shany S., Green M. S., Slepon R., Shinar E. Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin. Journal of Viral Hepatitis 1995; 2: 139–144
- Carter H., Robinson G., Hanlon C., Hailwood C., Massarotto A. Prevalence of hepatitis B and C infection in a methadone clinic population: Implications for hepatitis B vaccination. New Zealand Medical Journal 2001; 114: 324–326
- Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health 1996; 86: 655–661
- Glikberg F., Brawer-Ostrovsky J., Ackerman Z. Very high prevalence of hepatitis B and C in Bukharian Jewish immigrants to Israel. Journal of Clinical Gastroenterology 1997; 24: 30–33
- Gossop M., Marsden J., Stewart D., Treacy S. Reduced injection risk and sexual risk behaviours after drug misuse treatment: Results from the National Treatment Outcome Research Study. AIDS Care 2002; 14: 77–93
- Hawks R. L. Analytical methodology. NIDA Research Monograph 1986; 73: 30–42
- Koblin B. A., Factor S. H., Wu Y., Vlahov D. Hepatitis C virus infection among noninjecting drug users in New York City. Journal of Medical Virology 2003; 70: 387–390
- Maayan S., Shufman E. N., Engelhard D., Shouval D. Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem. Addiction 1994; 89: 869–874
- McLellan A. T., Luborsky L., O'Brien C. P., Barr H. L., Evans F. The Addiction Severity Index in three different populations. NIDA Research Monograph 1984; 55: 217–223
- NIH Consensus Statement. Effective medical treatment of opiate addiction. NIH Consensus Statement 1997; 15: 6
- Piccolo P., Borg L., Lin A., Melia D., Ho A., Kreek M. J. Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. Journal of Addictive Diseases 2002; 21: 55–66
- Stroffolini T., Lorenzoni U., Menniti-Ippolito F., Infantolino D., Chiaramonte M. Hepatitis C virus infection in spouses: Sexual transmission or common exposure to the same risk factors?. American Journal of Gastroenterology 2001; 96: 3138–3141